- Home
- ELVA vs ARMP Comparison
ELVA vs ARMP Comparison
Compare ELVA & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- ARMP
- Stock Information
- Founded
- ELVA 1996
- ARMP N/A
- Country
- ELVA Canada
- ARMP United States
- Employees
- ELVA N/A
- ARMP N/A
- Industry
- ELVA
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELVA
- ARMP Health Care
- Exchange
- ELVA Nasdaq
- ARMP Nasdaq
- Market Cap
- ELVA 88.7M
- ARMP 84.3M
- IPO Year
- ELVA N/A
- ARMP N/A
- Fundamental
- Price
- ELVA $2.22
- ARMP $2.20
- Analyst Decision
- ELVA Strong Buy
- ARMP Strong Buy
- Analyst Count
- ELVA 4
- ARMP 1
- Target Price
- ELVA $9.25
- ARMP $7.00
- AVG Volume (30 Days)
- ELVA 23.8K
- ARMP 9.5K
- Earning Date
- ELVA 08-13-2024
- ARMP 11-12-2024
- Dividend Yield
- ELVA N/A
- ARMP N/A
- EPS Growth
- ELVA N/A
- ARMP N/A
- EPS
- ELVA 0.02
- ARMP N/A
- Revenue
- ELVA $49,490,000.00
- ARMP $3,719,000.00
- Revenue This Year
- ELVA $20.03
- ARMP N/A
- Revenue Next Year
- ELVA $87.71
- ARMP N/A
- P/E Ratio
- ELVA $127.79
- ARMP N/A
- Revenue Growth
- ELVA 45.33
- ARMP N/A
- 52 Week Low
- ELVA $1.67
- ARMP $1.90
- 52 Week High
- ELVA $4.58
- ARMP $4.48
- Technical
- Relative Strength Index (RSI)
- ELVA 61.20
- ARMP 43.20
- Support Level
- ELVA $1.88
- ARMP $2.19
- Resistance Level
- ELVA $2.26
- ARMP $2.50
- Average True Range (ATR)
- ELVA 0.08
- ARMP 0.14
- MACD
- ELVA 0.05
- ARMP -0.00
- Stochastic Oscillator
- ELVA 94.87
- ARMP 17.71
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and industry leading battery longevity. Geographically it earns key revenue from the United States.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.